Work

Our focus on the pharmacogenetics of CRF1 antagonists is simply because they are in clinical development

Year: 2011

Type: article

Source: Nature reviews. Neuroscience

DOI: 10.1038/nrn3110-c2

Author: Markus Heilig

Institutions: National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism

Language: English

Topic: Neurotransmitter Receptor Influence on Behavior

Subfield: Cellular and Molecular Neuroscience

Field: Neuroscience

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1964922995

FWCI: 0.132

Cites: 6

Cited by: 1

Related to: 10